,,ii #aag? ,,congress #b;d ,session ,s4 #dddf ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,june #bb1 #bjbb,ms4 ,coll9s 7= h]self & ,mr4 ,ka9e7 introduc$ ! foll[+ bill2 :i* 0 read twice & ref]r$ to ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ,a ,,bill ,to mod]nize ! process ( accel]at$ approval ( a drug = a s]i\s or life-?reat5+ disease or condition4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,mod]niz+ ! ,accel]at$ ,approval ,pa?way ,act ( #bjbb4 #b4 ,mod]niz+ accel]at$ approval 7a7 ,9 g5]al ,section #ejf7;c7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cef7;c77 is am5d$-- 7#a7 9 p>agraph 7#b7-- 7,a7 by r$esignat+ subp>agraphs 7,a7 & 7,b7 z clauses 7i7 & 7ii71 respectively1 & adju/+ ! m>g9s accord+ly2 7,b7 by /rik+ ,approval ( a product & ins]t+ ! foll[+3 7,a7 ,9 g5]al ,approval ( a product 2 7,c7 9 clause 7i7 ( su* subp>agraph 7,a71 z s r$esignat$1 by /rik+ appropriate po/approval /udies & ins]t+ an appropriate po/approval /udy or /udies 7:i* may be augm5t$ or support$ by real _w evid5ce72 & 7,d7 by add+ at ! end ! foll[+3 7,b7 ,/udies n requir$ ,if ! ,secret>y does n require t ! sponsor ( a product approv$ "u accel]at$ approval conduct a po/approval /udy "u ?is p>agraph1 ! ,secret>y %all publi% on ! website ( ! ,food & ,drug ,adm9i/ration ! rationale = :y su* /udy is n appropriate or necess>y4 7,c7 ,po/approval /udy conditions ,n lat] ?an ! "t ( approval ( a product "u accel]at$ approval1 ! ,secret>y %all specify ! conditions = a po/approval /udy or /udies requir$ to be conduct$ "u ?is p>agraph ) respect to su* product1 :i* may include enrollm5t t>gets1 ! /udy protocol1 & mile/ones1 includ+ ! t>get date ( /udy completion4 7,d7 ,/udies ,begun ,be=e ,approval ,! ,secret>y may require su* /udy or /udies to be und]way prior to approval4 2 & 7#b7 9 p>agraph 7#c7-- 7,a7 by r$esignat+ subp>agraphs 7,a7 ?r\gh 7,d7 z clauses 7i7 ?r\gh 7iv71 respectively1 & adju/+ ! m>g9s accord+ly2 7,b7 by /rik+ ,! ,secret>y may & ins]t+ ! foll[+3 7,a7 ,9 g5]al ,! ,secret>y may 2 7,c7 9 clause 7i7 ( su* subp>agraph 7,a71 z s r$esignat$1 by /rik+ drug ) due dilig5ce & ins]t+ product ) due dilig5ce1 includ+ ) respect to conditions specifi$ by ! ,secret>y "u p>agraph 7#b77;,c72 7,d7 9 clause 7iii7 ( su* subp>agraph 7,a71 z s r$esignat$1 by ins]t+ %[n to be aft] product is n2 & 7,e7 by add+ at ! end ! foll[+3 7,b7 ,exp$it$ proc$ures describ$ ,exp$it$ proc$ures describ$ 9 ?is subp>agraph %all consi/ (1 prior to ! )drawal ( accel]at$ approval-- 7i7 provid+ ! sponsor )-- 7,i7 due notice2 7,,ii7 an explanation = ! propos$ )drawal2 7,,iii7 an opportunity = a meet+ ) ! ,commission] or ! ,commission]'s designee2 & 7,,iv7 an opportunity = writt5 appeal to-- 7aa7 ! ,commission]2 or 7bb7 a designee ( ! ,commission] :o has n p>ticipat$ 9 ! proposal )drawal ( approval 7o!r ?an a meet+ pursuant to subclause 7,,iii77 & is n subord9ate ( an individual 7o!r ?an ! ,commission]7 :o p>ticipat$ 9 su* propos$ )drawal2 7ii7 provid+ an opportunity = public comm5t on ! propos+ to )drawal approval2 7iii7 ! publication ( a summ>y ( ! public comm5ts receiv$1 & ! ,secret>y's response to su* comm5ts1 on ! website ( ! ,food & ,drug ,adm9i/ration2 & 7iv7 conv5+ & consult+ an advisory committee on issues relat$ to ! propos$ )drawal1 if reque/$ by ! sponsor & if no su* advisory committee has previ\sly advis$ ! ,secret>y on su* issues ) respect to ! )drawal ( ! product prior to ! sponsor's reque/4 4 7b7 ,reports ( po/m>ket+ /udies ,section #ejf;,b7a7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cef;b7a77 is am5d$-- 7#a7 by r$esignat+ p>agraph 7#b7 z p>agraph 7#c72 & 7#b7 by ins]t+ aft] p>agraph 7#a7 ! foll[+3 7#b7 ,accel]at$ approval ,not)/&+ p>agraph 7#a71 a sponsor ( a drug approv$ "u accel]at$ approval %all submit to ! ,secret>y a report ( ! progress ( any /udy requir$ "u section #ejf7;c71 includ+ progress t[>d enrollm5t t>gets1 mile/ones1 & o!r in=mation z requir$ by ! ,secret>y1 n lat] ?an #ahj days aft] ! approval ( su* drug & n less frequ5tly ?an e #ahj days !reaft]1 until ! /udy is complet$ or t]m9at$4 ,! ,secret>y %all promptly publi% on ! website ( ! ,food & ,drug ,adm9i/ration ! in=mation s report$1 9 an easily se>*able =mat4 4 7c7 ,en=cem5t ,section #cja ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cca71 is am5d$ by add+ at ! end ! foll[+3 7fff7 ,! failure ( a sponsor ( a product approv$ "u accel]at$ approval pursuant to section #ejf7;c7-- 7#a7 to conduct ) due dilig5ce any po/approval /udy requir$ "u section #ejf7;c7 ) respect to su* product2 or 7#b7 to submit timely reports ) respect to su* product 9 accordance ) section #ejf;,b7a77#b74 4 7d7 ,guidance 7#a7 ,9 g5]al ,! ,secret>y ( ,heal? & ,human ,s]vices %all issue guidance describ+-- 7,a7 h[ sponsor que/ions relat$ to ! id5tification ( novel surrogate or int]m$iate cl9ical endpo9ts may be address$ 9 e>ly-/age developm5t meet+s ) ! ,food & ,drug ,adm9i/ration2 7,b7 ! use ( novel cl9ical trial designs t may be us$ to conduct appropriate po/-approval /udies z may be requir$ "u section #ejf7;c77#b77;,a7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act1 z am5d$ by subsection 7a72 7,c7 ! exp$it$ proc$ures describ$ 9 section #ejf7;c77#c77;,b7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act2 & 7,d7 consid]ations relat$ to ! use ( surrogate or int]m$iate cl9ical endpo9ts t may support ! accel]at$ approval ( an application "u #ejf7;c77#a77;,a71 includ+ consid]ations 9 evaluat+ ! evid5ce relat$ to any su* endpo9ts4 7#b7 ,f9al guidance ,! ,secret>y %all issue-- 7,a7 draft guidance "u p>agraph 7#a7 n lat] ?an #ah mon?s aft] ! date ( enactm5t ( ?is ,act2 & 7,b7 f9al guidance n lat] ?an #a ye> aft] ! close ( ! public comm5t p]iod on su* draft guidance4 7e7 ,r>e disease endpo9t advancem5t pilot 7#a7 ,9 g5]al ,! ,secret>y ( ,heal? & ,human ,s]vices %all e/abli% a pilot program "u :i* ! ,secret>y w e/abli% proc$ures to provide increas$ int]action ) sponsors ( r>e disease drug developm5t programs = purposes ( advanc+ ! developm5t ( efficacy endpo9ts1 includ+ surrogate & int]m$iate endpo9ts1 = drugs int5d$ to treat r>e diseases1 includ+ ?r\gh-- 7,a7 det]m9+ eligibility ( p>ticipants = su* program2 & 7,b7 develop+ & implem5t+ a process = apply+ to1 & p>ticipat+ 91 su* a program4 7#b7 ,public work%ops ,! ,secret>y %all conduct up to #c public work%ops1 :i* %all be complet$ n lat] ?an ,septemb] #cj1 #bjbf1 to discuss topics relevant to ! developm5t ( endpo9ts = r>e diseases1 :i* may include discussions ab\t-- 7,a7 novel endpo9ts develop$ ?r\gh ! pilot program e/abli%$ "u ?is subsection2 & 7,b7 z appropriate1 ! use ( real _w evid5ce & real "w data to support ! validation ( efficacy endpo9ts1 includ+ surrogate & int]m$iate endpo9ts1 = r>e diseases4 7#c7 ,report ,n lat] ?an ,septemb] #cj1 #bjbg1 ! ,secret>y %all submit to ! ,committee on ,en]gy & ,comm]ce ( ! ,h\se ( ,repres5tatives & ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ( ! ,s5ate a report describ+ ! outcomes ( ! pilot program e/abli%$ "u ?is subsection4 7#d7 ,guidance ,n lat] ?an ,septemb] #cj1 #bjbg1 ! ,secret>y %all issue guidance describ+ be/ practices & /rategies = developm5t ( efficacy endpo9ts1 includ+ surrogate & int]m$iate endpo9ts1 = r>e diseases4 7#e7 ,sunset ,! ,secret>y may n accept any new application or reque/ to p>ticipate 9 ! program e/abli%$ by ?is subsection on or aft] ,octob] #a1 #bjbg4 7f7 ,accel]at$ approval c\ncil 7#a7 ,g5]al ,n lat] ?an #ahj days aft] ! date ( enactm5t ( ?is ,act1 ! ,secret>y ( ,heal? & ,human ,s]vices %all e/abli% an intra-ag5cy coord9at+ c\ncil )9 ! ,food & ,drug ,adm9i/ration to ensure ! consi/5t & appropriate use ( accel]at$ approval across ! ,food & ,drug ,adm9i/ration1 pursuant to section #ejf7;c7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cef7;c774 7#b7 ,memb]%ip ,! memb]s ( ! ,c\ncil %all consi/ ( ! foll[+ s5ior (ficials1 or a designee ( su* (ficial1 f ! ,food & ,drug ,adm9i/ration & relevant ,c5t]s3 7,a7 ,! ,director ( ! ,c5t] = ,drug ,evaluation & ,rese>*4 7,b7 ,! ,director ( ! ,c5t] = ,biologics ,evaluation & ,rese>*4 7,c7 ,! ,director ( ! ,oncology ,c5t] ( ,excell5ce4 7,d7 ,! ,director ( ! ,(fice ( ,new ,drugs4 7,e7 ,! ,director ( ! ,(fice ( ,orphan ,products ,developm5t4 7,f7 ,! ,director ( ! ,(fice ( ,tissues & ,advanc$ ,!rapies4 7,g7 ,! ,director ( ! ,(fice ( ,m$ical ,policy4 7,h7 ,at lea/ #c directors ( review division ov]see+ products approv$ "u accel]at$ approval1 includ+ at lea/ "o director ( a review division )9 ! ,(fice ( ,neurosci5ce4 7#c7 ,duties ( ! c\ncil 7,a7 ,meet+s ,! ,c\ncil %all conv5e n few] ?an #c times p] cal5d> ye> to discuss issues relat$ to accel]at$ approval1 includ+ any relevant cross-discipl9>y approa*es relat$ to product review ) respect to accel]at$ approval4 7,b7 ,policy developm5t ,! ,c\ncil %all directly engage ) product review teams to support ! consi/5t & appropriate use ( accel]at$ approval across ! ,food & ,drug ,adm9i/ration4 ,su* activities may include-- 7i7 develop+ guidance = ,food & ,drug ,adm9i/ration /aff & be/ practices =1 & across1 product review teams1 includ+ ) respect to communication betwe5 sponsors & ! ,food & ,drug ,adm9i/ration & ! review ( products "u accel]at$ approval2 7ii7 provid+ tra9+ = product review teams2 & 7iii7 advis+ review divisions on product-specific developm5t1 review1 & )drawal ( products "u accel]at$ approval4 7#d7 ,publication ( a report ,n lat] ?an #a ye> aft] ! date ( enactm5t ( ?is ,act1 & annually !reaft]1 ! c\ncil %all publi% on ! public website ( ! ,food & ,drug ,adm9i/ration a report on ! activities ( ! c\ncil4 7g7 ,rule ( con/ruction ,no?+ 9 ?is section 7includ+ ! am5dm5ts made by ?is section7 %all be con/ru$ to affect products approv$ pursuant to #ejf7;c7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cef7;c77 prior to ! date ( enactm5t ( ?is ,act4